Contribute Try STAT+ Today

The unique array of bacteria in a person’s gut can dramatically change how well they metabolize medicines, and could explain why some patients respond better to some drugs, according to a new study that examined the impact of the microbiome on more than 500 medicines.

The research, published Wednesday in Cell, is the first to look at how a patient’s full microbiome affected the breakdown of more than 500 different drugs. Earlier research published in Nature had examined the isolated impact of about 70 individual strains of bacteria on drug metabolization.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.